| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Brancaccio John P serves as a Director at OKYO and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 5 buys and 0 sells. Those positions are worth an estimated $197K at current prices.
The biggest single holding is CRDF (~$134K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 19,993 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2023 | OKYO Okyo Pharma Ltd | Director | Buy | 16,670 | $1.50 | $25,005.00 | New | -15.1% | -48.2% | |
| Mar 22, 2021 | CRDF Cardiff Oncology, Inc. | Director | Buy | 3,000 | $10.95 | $32,850.00 | +32.4% | -26.4% | -75.9% | |
| Dec 2, 2020 | HEPA Hepion Pharmaceuticals, Inc. | Director | Buy | 7,000 | $1.53 | $10,710.00 | +87,500% | - | - | |
| May 14, 2020 | CRDF Cardiff Oncology, Inc. | Director | Buy | 6,993 | $1.43 | $9,999.99 | +308.5% | - | - | |
| Jun 8, 2018 | CRDF Cardiff Oncology, Inc. | Director | Buy | 10,000 | $0.80 | $8,000.00 | +23.2% | - | - |